From GlobeNewswire: 2025-02-20 13:30:00

Roche has unveiled its groundbreaking sequencing by expansion (SBX) technology, a new category of next-generation sequencing that promises ultra-rapid, scalable sequencing for a wide range of applications, including cancer research and clinical applications. This technology reduces the time from sample to genome from days to hours, revolutionizing genomic research and healthcare. Roche’s SBX technology uses expanded synthetic molecules to determine the DNA sequence of a target molecule, offering unparalleled speed, efficiency, and flexibility in sequencing. This innovative approach opens up new possibilities for researchers and clinicians to make significant discoveries in genetics and disease treatment.



Read more at GlobeNewswire: Roche unveils a new class of next-generation sequencing